arrow
K

Kaaren K. Reichard

Mayo Clinic
H指数:34
被引数:3,604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia

基于第14天残留病灶和年龄适应巩固策略的再诱导需求对急性髓系白血病预后的影响

2026-09-300
OAAI
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia

CMML2AML:机器学习发现与慢性骨髓单核细胞白血病blast transformation相关的共突变和特异性单突变

2026-04-120
OAAI
One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol

慢性髓单核细胞白血病患者中1个、2个或≥3个TET2突变的比较:在包括BLAST-mol和CPSS-mol在内的当代预后模型背景下,探讨共突变模式及预后相关性

2026-04-040
OAAI
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly

青年型慢性髓单核细胞白血病(50岁及以下):与老年患者的临床及分子特征差异

CANCER
IF5.1
2025-11-150
OA
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group

具有RUNX1突变的模糊系急性白血病与具有RUNX1突变的急性髓系白血病相比,预后相似:一项来自骨髓病理学组的研究

2025-10-180
PRE
Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo–Humanitas Collaborative Project Involving 1101 Patients

BLAST和BLAST-Mol风险模型在慢性髓系单核细胞白血病中的验证:涉及1101例患者的Mayo–Humanitas合作项目

2025-09-250
PREAI
Triple A Plus (AAA+) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients

三重A加(AAA+)生存预测模型用于原发性血小板增多症:涉及7308例患者的分析

2025-09-030
OAAI
BLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia

BLAST:一种适用于全球范围且分子上具有多样性的慢性髓系单核细胞白血病患者生存模型

Blood
IF23.1
2025-05-090
PRE
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases

骨髓增殖性肿瘤和急性髓系白血病中的多突变TP53基因突变:142例有信息价值病例的生存和风险因素比较分析

2025-03-131
PRE